ClinicalTrials.gg
RecruitingNCT07670494Updated Jul 8, 2026

Mechanical Power During Different Ventilation Modes in Laparoscopic Surgery

An interventional study of Volume-Controlled Ventilation (VCV) and Pressure-Regulated Volume Control (PRVC) in Laparoscopic Cholecystectomy, Mechanical Ventilation and Ventilator-Induced Lung Injury, sponsored by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Jul 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study investigates how different breathing machine (ventilator) settings affect the energy delivered to the lungs during surgery. Mechanical power is a measure of this energy, and high levels can sometimes lead to lung irritation. In clinical practice, a mode called Pressure-Regulated Volume Control (PRVC) is often used because it lowers the "peak" pressure in the airways, which is generally thought to be safer. However, doctors have noticed that even though the peak pressure goes down in PRVC mode, the total mechanical power displayed on the monitor might actually increase compared to the standard Volume-Controlled Ventilation (VCV) mode. In this study, patients undergoing gallbladder surgery will be monitored using both ventilation modes in a random order. The researchers will compare the machine-calculated mechanical power for both modes to see if the perceived benefit of lower peak pressure in PRVC actually results in lower overall energy transfer to the lungs.

02

Conditions studied

  • Laparoscopic Cholecystectomy
  • Mechanical Ventilation
  • Ventilator-Induced Lung Injury
03

In context

Ventilator-Induced Lung Injury

120 studies on the registry are indexed under Ventilator-Induced Lung Injury; 39 are open to participants now.

This study's planned enrollment of 80 is above the median of 40 across 74 interventional studies indexed under Ventilator-Induced Lung Injury.

Browse Ventilator-Induced Lung Injury studies →

Lead sponsor

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital is the lead sponsor of 75 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing elective laparoscopic cholecystectomy surgery.
  • Patients between 18 and 75 years of age.
  • (ASA) physical status I, II or III.
  • (BMI) between 18.5 and 35 kg/m².
  • Voluntary written for participation.

Exclusion criteria

Exclusion Criteria:

  • History of significant (COPD) or asthma.
  • Previous lung resection or major thoracic surgery.
  • Heavy smokers (more than 20 cigarettes per day).
  • Presence of spontaneous breathing effort during mechanical ventilation.
  • Conversion from laparoscopic surgery to open surgery during the procedure.
  • Emergency surgery cases.
  • Known pregnancy.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    group A; VCV First, Then PRVC

    Following the stabilization of pneumoperitoneum, participants will be ventilated using the Volume-Controlled Ventilation (VCV) mode for 10 minutes. At the end of this period, respiratory data and mechanical power values will be recorded. Immediately after, the ventilator will be switched to the Pressure-Regulated Volume Control (PRVC) mode with equivalent settings. After another 10-minute stabilization period in PRVC mode, a second set of measurements will be recorded.

    Device: Volume-Controlled Ventilation (VCV) · Device: Pressure-Regulated Volume Control (PRVC)

  • Experimental
    group B; PRVC First, Then VCV

    Following the stabilization of pneumoperitoneum, participants will be ventilated using the Pressure-Regulated Volume Control (PRVC) mode for 10 minutes. At the end of this period, respiratory data and mechanical power values will be recorded. Immediately after, the ventilator will be switched to the Volume-Controlled Ventilation (VCV) mode with equivalent settings. After another 10-minute stabilization period in VCV mode, a second set of measurements will be recorded.

    Device: Volume-Controlled Ventilation (VCV) · Device: Pressure-Regulated Volume Control (PRVC)

Interventions

  • DeviceVolume-Controlled Ventilation (VCV)

    Participants will be ventilated with the traditional Volume-Controlled Ventilation (VCV) mode. Tidal volume, respiratory rate, PEEP, and I:E ratio will be set according to the study protocol and kept constant during the measurement period.

  • DevicePressure-Regulated Volume Control (PRVC)

    Participants will be ventilated with the Pressure-Regulated Volume Control (PRVC) mode. This is a hybrid mode that uses a decelerating flow to deliver the target tidal volume at the lowest possible pressure. Settings will be identical to the VCV mode for each patient.

06

What researchers measure

Primary outcomes

  1. Device-Displayed Mechanical Power

    The mechanical power value (expressed in Joules per minute - J/min) is automatically calculated and displayed on the monitor of the Mindray A9 anesthesia machine. This value represents the total energy delivered by the ventilator to the patient's respiratory system per minute. The study aims to compare how this machine-calculated value differs between the Volume-Controlled Ventilation (VCV) and Pressure-Regulated Volume Control (PRVC) modes under identical clinical conditions.

    Time frame: At the end of a 10-minute stabilization period in each ventilation mode (VCV and PRVC).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The de-identified individual participant data (including study protocol and statistical analysis plan) will be made available upon reasonable request to the corresponding author, following the publication of the study results.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07670494
Lead sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Responsible party
Arif Timuroğlu, MD (Principal Investigator, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital) — Principal investigator
First posted
Jun 26, 2026
Start date
Jul 1, 2026
Primary completion
Aug 10, 2026 (estimated)
Completion
Aug 12, 2026 (estimated)
Last update
Jul 8, 2026

Study contacts

arif timuroglu, MD
Contact
ariftimuroglu@yahoo.com
+905072601980

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion